Intensity Therapeutics is a clinical stage biotechnology company looking to greatly extend the life of cancer patients. Intensity’s approach is to directly inject tumors with highly tumor absorbable drug that kill cancer cells to create an immune response. When activated the immune system attacks the non-injected cancer is on constant surveillance against the cancer – all with minor or no side effects. Intensity needed a smart-looking, stylish brand to convey the technology’s potential power, interest investors and educate clinical trial patients or their physicians on the science.
Together Watermark and Intensity created a “bold brand” that conveyed the differentiators of the Intensity science/technology. It was essential for Watermark to provide strong graphics in support of their story that encourages readers to understand their unique approach. The Intensity Therapeutics website has recently been awarded a platinum AVA Digital Award.